Metraipolis › archive › dc_7ab75cc6b7ed

A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42843344
DOI
10.1016/j.xcrm.2026.103095
License (as archived)
solo-consultazione
Archived
2026-11-01T07:07:41.029Z
SHA-256 of the archived text
c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d
Stable URL of this page
https://metraipolis.com/documento/dc_7ab75cc6b7ed

How to cite

A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344 — Europe PMC (en), https://europepmc.org/article/MED/42843344 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ab75cc6b7ed (Metraipolis archive dc_7ab75cc6b7ed, sha256 c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d)
BibTeX
@misc{dc7ab75cc6b7ed,
  title = {A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42843344},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ab75cc6b7ed; sha256 c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42843344. Agents can read the archived copy with the MCP tool read_document.